Published August 2013 | Version v1
Journal article

Radiosynthesis and biological evaluation of 5-(3-[18F]Fluoropropyloxy)-L-tryptophan for tumor PET imaging

  • 1. PET Center, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou 510080 (China)
  • 2. PET-CT center, Department of Nuclear Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080 (China)
  • 3. Department of Applied Chemistry, South China Agricultural University, Guangzhou 510642 (China)

Description

Introduction: [18F]FDG PET has difficulty distinguishing tumor from inflammation in the clinic because of the same high uptake in nonmalignant and inflammatory tissue. In contrast, amino acid tracers do not accumulate in inflamed tissues and thus provide an excellent opportunity for their use in clinical cancer imaging. In this study, we developed a new amino acid tracer 5-(3-[18F]Fluoropropyloxy)-L-tryptophan ([18F]-L-FPTP) by two-step reactions and performed its biologic evaluation. Methods: [18F]-L-FPTP was prepared by [18F]fluoropropylation of 5-hydroxy-L-tryptophan disodium salt and purification on C18 cartridges. The biodistribution of [18F]-L-FPTP was determined in normal mice and the incorporation of [18F]-L-FPTP into tissue proteins was investigated. In vitro competitive inhibition experiments were performed with Hepa1-6 hepatoma cell lines. [18F]-L-FPTP PET imaging was performed on tumor-bearing and inflammation mice and compared with [18F]-L-FEHTP PET. Results: The overall uncorrected radiochemical yield of [18F]-L-FPTP was 21.1 ± 4.4% with a synthesis time of 60 min, the radiochemical purity was more than 99%. Biodistribution studies demonstrate high uptake of [18F]-L-FPTP in liver, kidney, pancreas, and blood at the early phase, and fast clearance in most tissues over the whole observed time. The uptake studies in Hepa1-6 cells suggest that [18F]-L-FPTP is transported by the amino acid transport system B0,+, LAT2 and ASC. [18F]-L-FPTP displays good stability and is not incorporated into proteins in vitro. PET imaging shows that [18F]-L-FPTP can be a better potential PET tracer for differentiating tumor from inflammation than [18F]FDG and 5-(3-[18F]fluoroethyloxy)-L-tryptophan ([18F]-L-FEHTP), with high [18F]-L-FPTP uptake ratio (2.53) of tumor to inflammation at 60 min postinjection. Conclusions: Using [18F]fluoropropyl derivatives as intermediates, the new tracer [18F]-L-FPTP was achieved with good yield and radiochemical purity, and the biological evaluation results of [18F]-L-FPTP showed that it was a hopeful tracer for PET tumor imaging

Availability note (English)

Available from http://dx.doi.org/10.1016/j.nucmedbio.2013.04.013

Additional details

Identifiers

DOI
10.1016/j.nucmedbio.2013.04.013;
PII
S0969-8051(13)00107-8;

Publishing Information

Journal Title
Nuclear Medicine and Biology
Journal Volume
40
Journal Issue
6
Journal Page Range
p. 801-807
ISSN
0969-8051
CODEN
NMBIEO

Optional Information

Copyright
Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.